NASDAQ: SNDXSyndax Pharmaceuticals Inc Stock Ownership - Who owns Syndax Pharmaceuticals?
Insider buying vs selling
Have Syndax Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Michael A. Metzger | Chief Executive Officer | 2025-03-14 | 6,074 | $7.20 | $43.73kBuy |
| Michael A. Metzger | Chief Executive Officer | 2025-03-04 | 7,814 | $7.20 | $56.26kBuy |
| Michael A. Metzger | Chief Executive Officer | 2025-03-04 | 7,814 | $15.05 | $117.56kSell |
| Michael A. Metzger | Chief Executive Officer | 2025-02-10 | 13,288 | $15.50 | $206.02kSell |
| Keith A. Goldan | Chief Financial Officer | 2025-02-10 | 3,777 | $15.50 | $58.56kSell |
| Neil Gallagher | President Head of RD | 2025-02-10 | 4,618 | $15.50 | $71.60kSell |
| Keith A. Goldan | Chief Financial Officer | 2024-06-14 | 1,250 | $20.03 | $25.04kBuy |
SNDX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when SNDX insiders and whales buy or sell their stock.
SNDX Shareholders
What type of owners hold Syndax Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 10.50% | 9,033,949 | $116.72M | Institution |
| Kynam Capital Management LP | 9.90% | 8,520,000 | $110.08M | Institution |
| Goldman Sachs Group Inc | 6.92% | 5,950,537 | $76.88M | Institution |
| Morgan Stanley | 6.18% | 5,312,822 | $68.64M | Institution |
| Vanguard Group Inc | 5.68% | 4,881,968 | $63.08M | Institution |
| Wellington Management Group LLP | 4.92% | 4,234,455 | $54.71M | Institution |
| State Street Corp | 4.55% | 3,917,516 | $50.61M | Institution |
| Stempoint Capital LP | 3.34% | 2,872,601 | $37.11M | Institution |
| Soleus Capital Management LP | 2.90% | 2,492,000 | $32.20M | Institution |
| Avoro Capital Advisors LLC | 2.64% | 2,275,000 | $29.39M | Institution |
SNDX vs Biotech Stocks
Syndax Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.